Closed Loop Medicine and Pharmanovia Enter into Partnership
Wednesday, May 17, 2023
Closed Loop Medicine and Pharmanovia, announced that they have entered a global co-development partnership. The partnership will initially focus on the development and launch of a drug + software combination version of a first-line anti-hypertensive in the UK, before phased global roll-out and additional therapies are added.
This co-development agreement, will bring IP, insight and technical know-how of dose optimised drug plus software integration alongside Pharmanovia’s innovative business model, to enable well-known and trusted brands to be positioned as value-driven precision medicine product solutions globally.
Together it delivers a first in class combination regulated software and medicine – with the aim of delivering better patient outcomes, while enabling healthcare systems to reduce costly hospital procedures through better adherence and patient engagement.
Combining experience in lifecycle management with Closed Loop Medicine’s unique approach and technology is an exciting next step in the strategy. It enables to use innovative technology to enhance established medicines and bring much needed innovation to an area of large-scale unmet need.
